Long-term treatment effects of soticlestat in patients with Dravet syndrome or Lennox-Gastaut syndrome: interim data from the ENDYMION 1 trial

被引：0
|
作者：
Asgharnejad, M. [1 ]
Yao, Y. [1 ]
Dlugos, D. [2 ]
Mitra, P. [1 ]
Murthy, V. [1 ]
机构：
[1] Takeda Pharmaceut Co Ltd, Cambridge, MA USA
[2] Childrens Hosp Philadelphia, Philadelphia, PA USA
来源：
EPILEPSIA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
470
引用
收藏
页码：291 / 291
页数：1
相关论文
共 50 条
  • [31] No optimal treatment yet for patients with Lennox-Gastaut syndrome
    不详
    Drugs & Therapy Perspectives, 1999, 14 (5) : 10 - 12
  • [32] Optimizing clobazam treatment in patients with Lennox-Gastaut syndrome
    Isojarvi, Jouko
    Gidal, Barry E.
    Chung, Steve
    Wechsler, Robert T.
    EPILEPSY & BEHAVIOR, 2018, 78 : 149 - 154
  • [33] The efficacy and safety of fenfluramine in the treatment of Dravet syndrome and Lennox-Gastaut syndrome: evidence from randomized controlled trials
    Xu, Y.
    Chen, Y.
    Liu, L.
    EPILEPSIA, 2023, 64 : 290 - 290
  • [34] Understanding Lennox-Gastaut syndrome: insights from focal epilepsy patients with Lennox-Gastaut features
    Dupont, Sophie
    Banica-Wolters, Raluca
    An-Gourfinkel, Isabelle
    Lambrecq, Virginie
    Navarro, Vincent
    Adam, Claude
    Nguyen-Michel, Vi-Huong
    JOURNAL OF NEUROLOGY, 2017, 264 (07) : 1388 - 1396
  • [35] Long-term courses of West and Lennox-Gastaut syndrome [Langzeitverläufe von Westund Lennox-Gastaut-Syndrom]
    Ernst J.-P.
    Zeitschrift für Epileptologie, 2008, 21 (1): : 26 - 29
  • [36] Lennox-Gastaut Syndrome Symptomatic to Hypothalamic Hamartoma: Evolution and Long-Term Outcome
    Liu, Ming-Jai
    Pati, Sandipan
    Deep, Aman
    Ng, Yu-tze
    NEUROLOGY, 2012, 78
  • [37] Practical considerations for the use of fenfluramine to manage patients with Dravet syndrome or Lennox-Gastaut syndrome in clinical practice
    Wirrell, Elaine C.
    Lagae, Lieven
    Scheffer, Ingrid E.
    Cross, J. Helen
    Specchio, Nicola
    Strzelczyk, Adam
    EPILEPSIA OPEN, 2024, 9 (05) : 1643 - 1657
  • [38] Efficacy, Safety and Tolerability of Soticlestat (TAK-935/OV935) as Adjunctive Therapy in Pediatric Patients with Dravet Syndrome and Lennox-Gastaut Syndrome (ELEKTRA)
    Hahn, Cecil D.
    Jiang, Yuwu
    Villanueva, Vincente
    Zolnowska, Marta
    Arkilo, Dimitrios
    Forgacs, Peter B.
    Asgharnejad, Mahnaz
    Yan, Ying
    Dlugos, Dennis
    NEUROLOGY, 2021, 96 (15)
  • [39] Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox-Gastaut Syndrome
    Iannone, Luigi Francesco
    Arena, Gabriele
    Battaglia, Domenica
    Bisulli, Francesca
    Bonanni, Paolo
    Boni, Antonella
    Canevini, Maria Paola
    Cantalupo, Gaetano
    Cesaroni, Elisabetta
    Contin, Manuela
    Coppola, Antonietta
    Cordelli, Duccio Maria
    Cricchiuti, Giovanni
    De Giorgis, Valentina
    De Leva, Maria Fulvia
    De Rinaldis, Marta
    d'Orsi, Giuseppe
    Elia, Maurizio
    Galimberti, Carlo Andrea
    Morano, Alessandra
    Granata, Tiziana
    Guerrini, Renzo
    Lodi, Monica A. M.
    La Neve, Angela
    Marchese, Francesca
    Masnada, Silvia
    Michelucci, Roberto
    Nosadini, Margherita
    Pilolli, Nicola
    Pruna, Dario
    Ragona, Francesca
    Rosati, Anna
    Santucci, Margherita
    Spalice, Alberto
    Pietrafusa, Nicola
    Striano, Pasquale
    Tartara, Elena
    Tassi, Laura
    Papa, Amanda
    Zucca, Claudio
    Russo, Emilio
    Mecarelli, Oriano
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [40] Cannabidiol for Treatment of Patients With Seizures Associated With Lennox-Gastaut Syndrome
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (04) : 546 - 546
12345